MSD Animal Health Presents New Research on Swine Health
MSD Animal Health recently presented new research on their broad portfolio of swine health products at the 14th European Symposium on Swine Health Management (ESPHM). One of the notable products highlighted was their PORCILIS intradermal vaccine Lawsonia ID. This intradermal vaccination has been shown to reduce mortality and improve feed efficiency, as revealed by MSD Animal Health during the symposium held in Thessaloniki, Greece from May 31 to June 2.
Tackling Lawsonia intracellularis
Lawsonia intracellularis is a common pathogen in pig farms worldwide, causing diarrhea and poor growth in animals, leading to economic losses. While acute disease typically affects pigs between four and twelve months old, chronic disease can occur as early as six weeks. Intradermal vaccination with PORCILIS Lawsonia ID is expected to provide immunity within four weeks.
Reducing Bacterial Load and Improving Weight Gain
In addition to alleviating symptoms associated with the infection, intradermal vaccination has been found to decrease the bacterial load in pig feces, resulting in improved daily weight gain. The research demonstrates a correlation between the number of bacteria in the feces and the severity of the disease. By reducing the bacterial load through vaccination, the symptoms in growing pigs can be mitigated.
Advancements in Reproductive and Respiratory Health
During the ESPHM, MSD Animal Health also highlighted the use of new generation sequencing to characterize changes in intestinal viruses associated with cachexia in piglets. Additionally, they showcased the accuracy of the rapid blood progesterone kit (Biovet Progesterone Kit) in assessing progesterone (P4) levels to control reproductive problems in gilts and prevent unnecessary slaughter.
Respiratory pathology remains a significant challenge, particularly with the increasing prevalence and severity of diseases like the Reproductive and Respiratory Syndrome of Pigs (PRRS). MSD Animal Health presented data showing that vaccination of piglets, combined with improved biosecurity and management measures, is an effective and profitable approach for controlling the virus during the transition phase.
Commitment to Animal Health
MSD Animal Health actively contributes scientific input to the ESPHM congress. This year, they presented 19 communications, with eight of them coming from the Spanish team. The company’s commitment to promoting healthier animals is evident in the content of their research papers, which focus on enhancing intestinal and respiratory health, improving management practices, and increasing farm efficiency.
Rika Jolie, MSD Animal Health Global Technical Director, emphasized the company’s dedication to improving pig health, farm sustainability, and overall well-being. Through their innovative portfolio of vaccines, health management solutions, and value-added services, MSD Animal Health continues to advance scientific knowledge for the benefit of both pigs and farmers.
